SERB Specialty Pharmaceuticals is a leading pan-European specialty pharmaceutical group, providing globally a reliable supply of prescription medicines to patient suffering from…
@2021 – All Right Reserved. Designed and Developed by Prittle Prattle
Category:
Pharmacy
ATI Physical Therapy, we are passionate about potential. BOLINGBROOK, Ill., March 1, 2021 ATI Physical Therapy (ATI), one of the nation’s largest…
Hansa Biopharma is leveraging its proprietary enzyme technology platform to develop immunomodulatory treatments for enabling transplantations LUND, Sweden, March 1, 2021 Hansa…
- Pharmacy
BioInvent and Transgene has enrolled first patient in Phase I/IIa trial of novel oncolytic virus BT-001 in solid tumors
BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical stage company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer…
- Pharmacy
Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a leading clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines SHANGHAI and HONG KONG,…
Glenmark Ryaltris Nasal Spray, the company’s respiratory pipeline asset, is currently under review with the U.S. Food and Drug Administration (FDA) as…
ESSA Pharma is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients suffering from prostate…
- Pharmacy
Luye Pharma and Towa Pharmaceutical Enter Strategic Collaboration to Develop and Commercialize Rivastigmine Multi-Day Transdermal Patch in Japan
Luye Pharma and indicated for the treatment of Alzheimer’s disease, Rivastigmine MD employs an innovative drug delivery system BASEL, Switzerland, Feb. 18,…
- Pharmacy
Jazz Pharmaceuticals Announces Participation in the Leerink 10th Annual Global Healthcare Conference
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company dedicated to developing and commercializing life-changing medicines DUBLIN, Feb. 17, 2021 Jazz…
- Pharmacy
Citius Pharmaceuticals Announces $76.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Citius Pharmaceuticals is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on…
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies TARRYTOWN, N.Y., Feb. 12, 2021 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)…
- Pharmacy
Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV® (enfortumab vedotin-ejfv) in Patients with Previously Treated Advanced Urothelial Cancer
Astellas and Seagen are co-developing enfortumab vedotin under a collaboration that was entered into in 2007 and expanded in 2009. TOKYO…
- FinanceMelangePharmacy
Glenmark consolidated Net Profit rises by 30.05% to Rs. 2481.79 Mn. in Q3 FY 2020-21
Glenmark Pharmaceuticals Ltd. (GPL) is a global research-led pharmaceutical company with presence across Generics, MUMBAI, Feb. 12, 2021 Glenmark consolidated sales rises by…
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies.…
Starpharma has previously demonstrated the significant advantages conveyed by DEP® ADCs in multiple preclinical studies MELBOURNE, Australia, Feb. 11, 2021 Starpharma (ASX: SPL,…
- CompanyPharmacyPress Release
Protalix BioTherapeutics Announces Pricing of its Upsized Public Offering of Common Stock
Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins CARMIEL, Israel, Feb. 11, 2021 – Protalix…
- Pharmacy
Actinium Showcases Targeted Conditioning Program with 2 Oral Presentations Highlighting Iomab-B and Pivotal Phase 3 SIERRA Trial at 2021 Transplantation & Cellular Therapy Annual Meeting
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing ARCs or Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the…
- CompanyPharmacyPress Release
Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients
Artios Pharma Limited (“Artios”), a leading DNA Damage Response (DDR) company CAMBRIDGE, England and NEW YORK, Feb. 11, 2021 – Artios Pharma…
- CompanyPharmacyPress Release
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Gel USP, 1%
Glenmark current portfolio consists of 169 products authorized for distribution in the U.S. marketplace and 42 ANDA’s pending approval with the U.S.…
- CompanyPharmacyPress Release
Scopus BioPharma Announces Closing of Underwriters’ Over-Allotment Option in Full
Scopus is a biopharmaceutical company developing transformational therapeutics based on groundbreaking scientific and medical discoveries NEW YORK, Feb. 10, 2021 – Scopus BioPharma…
- DoctorPharmacy
Transcenta Holding Announces Appointment of Dr. Michael Shi as Executive Vice President, Head of Global R&D and Chief Medical Officer
Transcenta is a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, development and manufacturing. SUZHOU, China, Feb. 10, 2021 – Transcenta…
Atulya Unveils Committed to finding new ways to make lives better, Beacon Bio Life Sciences Private Limited (Beacon Bio) has launched its…
- BusinessCompanyInternationalPharmacyPress Release
Sihuan Pharmaceutical (0460.HK) The sole agent of Letybo 100U China AI Listing Conference was successfully held
Exclusively represented by Sihuan Pharmaceutical Holdings Group Ltd. (the “Company” or ” Sihuan Pharmaceutical “,
- BusinessCompanyPharmacyPress Release
The Bilgrav School Selects The BIOPROTECTUs™ System To Safefuard Its Facilities
Bilgrav School, an Orton-Gillingham-based school dedicated to dyslexic and twice exceptional students, has selected ViaClean
- BusinessCompanyHealthPharmacy
Astellas’ XOSPATA® (gilteritinib) Receives Conditional Approval by China’s National Medical Products Administration for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation
Astellas Pharma Inc. TSE: 4503, President today announced that the China National Medical Products Administration
- Pharmacy
EmpiRx Health Unveils a Pharmacogenomics Solution, Powered by OneOme, for Enhanced Clinical-Decision Making
EmpiRx Health, the industry’s only value-based pharmacy benefit manager (PBM), today unveiled its pharmacogenomics (PGx) solution, designed to improve health outcomes and…
- HealthInternationalPharmacyPress Release
AppointmentPlus Surpasses One Million COVID-19 Vaccine Appointments
AppointmentPlus enterprise appointment scheduling software surpassed one million COVID-19 vaccine appointments
Alfa Laval AB (publ) Fourth quarter and full year 2020The cash flow from operating activities improved by close
- HealthHealth updatesPharmacyPress Release
Glenmark Pharmaceuticals receives ANDA approval for Topiramate Extended-release Capsules, 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg
Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration
Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company
Newer Posts